Received Nov 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Inappropriate reconstitution technique; This non-serious case was reported by the other health professional via call center representative and described the occurrence of wrong technique in product usage process in a patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis. On an unknown date, the patient received Pediarix. On an unknown date, an unknown time after receiving Pediarix, the patient experienced wrong technique in product usage process (Verbatim: Inappropriate reconstitution technique). The outcome of the wrong technique in product usage process was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt Date: 05-NOV-2025 The reporter knew the syringe needed to be shaken she did not realize it needed to be shaken vigorously. The batch number was not provided, and we are unable to contact the reporter.